Pure Global: Cracking Brazil's New MedTech Cybersecurity Code - ANVISA's Unexpected Hurdle.

Brazil's health agency, ANVISA, has just introduced a stringent new cybersecurity regulation for all connected medical devices. This sudden move, aimed at enhancing patient safety and data protection, presents immediate and complex challenges for manufacturers. It escalates compliance costs and extends timelines, demanding a new level of technical documentation that many were not prepared for. This podcast episode breaks down what the new rules demand and explores the strategic implications for companies operating in Latin America's largest market. We analyze the specific requirements, the reasons behind this abrupt shift, and how it will reshape the competitive landscape for both local and international MedTech firms. **Key Takeaways:** * What are the three core technical requirements of ANVISA's new cybersecurity rule? * How does this new mandate affect devices already on the Brazilian market versus new submissions? * Why is this change happening now, and is it part of a larger LATAM regulatory trend? * What are the biggest compliance blind spots for foreign manufacturers entering Brazil? * Can proactive compliance with this new rule become a competitive advantage? * How will this impact the device registration timeline and budget for 2026? * What specific documentation, like a Software Bill of Materials, is now non-negotiable? Is your MedTech device ready for Brazil's new cybersecurity landscape? At Pure Global, we offer end-to-end regulatory consulting for MedTech and IVD companies. We combine local expertise with advanced AI to streamline your market access and ensure you stay ahead of critical changes like this. Don't let regulatory surprises derail your strategy. Contact Pure Global at [email protected] or visit us at https://pureglobal.com/.